Anti-oxidative Effect of
Ligustrazine on Treatment and Prevention of
Atherosclerosis
Gui-dong Huang,
Jian Mao* and Zhong-wei Ji
State Key Laboratory of Food
Science and Technology, School of Food Science and
Technology, Jiangnan University, Wuxi 214122, PR China
*For correspondence:
Email:
maojiand417@163.com; Tel:
+86-510-8532-9062; Fax: +86-510-8591-2155
Received: 11 July 2013 Revised accepted: 24 October
2013
Tropical Journal of
Pharmaceutical Research, December 2013;
12(6): 949-957
http://dx.doi.org/10.4314/tjpr.v12i6.13
Purpose: To investigate the protective
effects of ligustrazine on oxidative stress-induced
atherosclerosis.
Methods: The indicators related to oxidative
stress were determined using commercially available
assay kits. MTT assay was used to assess the survival
rate of human umbilical vein endothelial cells (HUVECs).
HUVECs apoptosis was analyzed using fluorescence
staining and flow cytometry. mRNA expression level and
activity of caspases 3, 8, and 9 were determined via
quantitative real-time polymerase chain reaction (PCR)
and caspase 3, 8, and 9 assay kits.
Results: Ligustrazine concentration of <
80 µmol/L had negligible inhibitory effect on HUVECs
viability and protected HUVECs against oxygen stress
damage by regulating the indicators related to oxidative
stress. Flow cytometry results show that ligustrazine
ameliorated H2O2-induced
apoptosis, while the proportion of cells that stepped
into early apoptosis and late apoptosis or necrosis were
52.7 and 0.6 %, respectively, in the H2O2
group, and 38.2 and 1.3 %, respectively, in the
ligustrazine group. In addition, ligustrazine attenuated
the up-regulation of caspase 3, 8, and 9 mRNA expression
levels and activity.
Conclusion: Ligustrazine can protect HUVECs
against H2O2-induced injuries by
regulating the indicators related to oxidative stress
and suppressing the overexpression of caspases 3, 8, and
9. The protective mechanism of ligustrazine on H2O2-induced
injury in HUVECs may be a caspase-dependent
anti-apoptotic mechanism which provide important
information for treating and preventing oxidative
stress-induced atherosclerosis.
Keywords: Ligustrazine, Oxidative stress,
Umbilical vein, Endothelial cells, Atherosclerosis